West Pharmaceutical Services, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
3/10
|
45.04 | 114.5 | -60.67% | 47.49 | -5.16% |
| P/S |
|
9.06 | 4.13 | 119.56% |
|
|
| P/BV |
|
9.28 | 9.44 | -1.76% |
|
|
| P/FCF |
|
69.1 | 44.62 | 54.86% |
|
|
| Ev/Ebitda |
|
29.9 | 17.79 | 68.1% |
|
|
| Ev/S |
|
8.88 | 4.42 | 100.81% |
|
|
| Ev/FCF |
|
63.16 | 54.85 | 15.15% |
|
|
| E/P |
|
0.0207 | 0.2136 | -90.31% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
29.69 | 20.25 | 46.62% | 28.83 | +2.96% |
| ROE |
|
20.6 | -80.86 | -125.47% |
|
|
| ROA |
|
15.5 | 6.71 | 130.98% |
|
|
| ROIC |
|
28.73 | 15.68 | 83.27% |
|
|
| ROS |
|
20.12 | 10.27 | 95.93% |
|
|
| ROCE |
|
25.63 | 57.54 | -55.46% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.2564 | 1.19 | -78.46% | 0.3214 | -20.24% |
| Nеt Debt/Ebitda |
|
-0.6222 | 2.27 | -127.42% |
|
|
| Debt/Ratio |
|
0.0586 | 0.2655 | -77.92% |
|
|
| Debt/Equity |
|
0.1938 | 4.84 | -95.99% |
|
|
| Debt/Net Income |
|
0.3783 | 35.64 | -98.94% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0.6/10
|
0.242 | 1.32 | -81.65% | 0.2223 | +8.86% |
| Number of years of dividend growth |
|
2 | 6.41 | -68.81% | ||
| DSI |
|
0.9286 | 0.7433 | 24.92% |
|
|
| Average dividend growth |
|
6.46 | -2.39 | -370.82% |
|
|
| Average percentage for 5 years |
|
0.2223 | 1.3 | -82.85% |
|
|
| Average percentage for payments |
|
53.11 | 77.74 | -31.68% |
|
|
| Difference from average difference in sector |
|
-1.08 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
60.32 | 260.11 | -76.81% | ||
| Growth impulse Ebitda in 5 years |
|
111.08 | 275.1 | -59.62% | ||
| Growth impulse Net Income in 5 years |
|
145.51 | 327.28 | -55.54% | ||
| Growth impulse FCF in 5 years |
|
72.13 | 232.6 | -68.99% | ||
| Growth impulse EPS in 5 years |
|
145.5 | 140.49 | 3.57% |
IP Score
6.99/10
